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Vincent Jarlier1*, Jean Carlet2, John McGowan3, Herman Goossens4, Andreas Voss5, Stephan Harbarth6 and
Didier Pittet6 the Participants of the 3rd World Healthcare-Associated Infections ForumOver 70 international experts in medicine, infectious
diseases, microbiology and epidemiology (see list in
Additional file 1: Annex 1), coming from 33 coun-
tries, met from June 27–29 June 2011 in Annecy (France)
for the third edition of the World HAI Forum on health-
care-associated infections. The aim of this meeting was to
release a global call to action to fight antibiotic resistance.
While most meetings focus on scientific developments
retrospectively in an academic format, World HAI Forums,
which are held every two years, gives participating experts
a chance to do prospective analysis of subjects that are not
usually discussed [1]. A large part of the time is devoted to
sharing best practices, successes and failures in the fight
against health care associated infections and resistant bac-
teria, as a basis for building effective action plans.
The 3rd world HAI forum was entirely dedicated to the
challenge represented by the increase in antibiotic resist-
ance. Indeed, while research to discover novel antibiotics
has slowed to a virtual standstill, bacterial resistance has
increased due (a) to the massive use and misuse of antibio-
tics, not only for human health, but also for animals and
(b) to the cross transmission of resistant bacteria in the
health care setting and in the community due to insuffi-
cient levels of hygiene. The treatment of certain common
infections is becoming difficult because of antibiotic resist-
ance and, concurrently, the success of immunosuppressive
therapies and surgical interventions (organ transplants,
cardiac surgery. . .), which are associated with a high risk
of bacterial infection due to resulting host compromise.
To the Forum experts, the current emergence in Europe
of pan-resistant NDM-1 bacteria and the epidemic of multi-
drug-resistant E. coli infections should be taken as a major
public health warning, indicating that a new era of anti-
microbial resistance has begun. This must lead to a global
awakening: the protection of antibiotics has now entered the
sphere of sustainable development.* Correspondence: vincent.jarlier@psl.aphp.fr
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reproduction in any medium, provided the orForum participants (33 countries indicated above) pre-
sented and discussed programs for surveying and control-
ling health care associated infections and antibiotic
resistance. These programs and related success stories
were mainly presented as posters (see list in Additional file
2: Annex 2, with links to actual posters) whose content
was thoroughly discussed during several specific sessions.
These posters also were displayed during the 1st Inter-
national Conference on Prevention and Infection Control
(ICPIC) held in Geneva in July 2011.
The content of these posters, and the main results
obtained following the implementation of these programs,
has been summarized thereafter in a world map (Figure 1).
For that purpose, they have been classified in five categories
depending on their scope: (a) Antibiotic stewardship and in-
fection control, (b) Antibiotic stewardship, (c) Infection con-
trol, (d) Survey (antibiotic consumption, bacterial resistance
to antibiotics, health care associated infections and (e) Inter-
national action. These programs have in many places led to
a decrease in antibiotic consumption and antibiotic resist-
ance (e.g. in organisms such as MRSA, VRE, carbapenem re-
sistant enterobacteria, and Pseudomonas aeruginosa).
In a continuation of calls to action and proposals made
by major national and international organizations (WHO,
ECDC, IDSA, CDC, etc.), and in addition to a collective
position paper [2], the Forum’s participants (see list in
Additional file 1: Annex 1) voted to rank by priority 24
messages to prevent an impending public health catastro-
phe caused by the emergence and spread of bacteria that
are resistant to all antibiotics. The ranking of these mes-
sages was organized in 4 groups corresponding to distinct
categories of stakeholders: national and international health
authorities and policy makers, the medical and veterinary
communities, the general public, and Industry. The results
of the ranking are displayed in Additional file 3: Annex 3.
Based on the results of the vote, the 24 messages have
been synthesized to be easily presented as 12 actions to
be implemented in the short to mid-term, as follows.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Summary of the content and results of national and international programs for surveying and controlling health care
associated infections and antibiotic resistance, presented as posters at the 3rd world HAI forum. The posters have been classified in five
categories depending on their scope: (a) Antibiotic stewardship and infection control, (b) Antibiotic stewardship, (c) Infection control, (d) Survey
(antibiotic consumption, bacterial resistance to antibiotics, health care associated infections and (e) International action. Symbols used: ↘ =
diminution; C = antibiotic consumption; MRSA=methicillin resistant Staphylococcus aureus; VRE = vancomycin resistant enterococci;
CRE = carbapenem resistant enterobacteria; MDRO=multidrug resistant organisms; R = bacterial resistance.
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– For animals, stop the administration of antibiotics
used in human medicine and limit antibiotics to
therapeutic use only. It is imperative to reserve
the most important classes of antibiotics for
humans.
– Banish, in all countries, the use of antibiotics as
growth promoters in animal feed.
– Regulate the sale of antibiotics for use in human
medicine and prohibit over-the-counter sales
worldwide.
– Have international organizations (WHO, European
Union) develop a charter on good antibiotic
stewardship and have all the ministries of health
worldwide sign it and commit to respecting it.Priority actions for the human and veterinary
healthcare communities
– Establish standardized, universal surveillance of
antibiotic use and resistance and monitor the
emergence and spread of new forms of bacterial
resistance.
– Include, in medical and veterinary school curricula, a
solid training in bacterial resistance and the prudent
use of antibiotics and establish on-the-job training
programs for healthcare workers, taking into
account the cultural specificities of each country.
Priority actions for the general public
– Develop culturally sensitive awareness campaigns,
targeted to the general public, explaining the
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only when absolutely necessary.
– Provide education about fundamental hygiene, such
as handwashing, to prevent the spread of infection.
It is imperative to improve sanitation systems to
eliminate resistant bacteria in wastewater.
– Include consumers in the development and
implementation of action plans.
Priority actions for industry
– Develop point-of-care and rapid diagnostic tests,
which can be used at the patient’s bedside or in the
doctor’s office, to guide the prescription of
antibiotics and avoid their prescription for viral
infections.
– Stimulate research and development of novel
antibiotics.
– Find new economic models which reconcile public
health interests with Industry needs for profitability.
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Additional file 1: Annex1 - Participants in the 3rd World HAI Forum.
Additional file 2: Annex 2 - List of posters presenting national and
international programs for surveying and controlling health care
associated infections and antibiotic resistance at the 3rd world HAI
forum.*
Additional file 3: Annex 3 - Result of the vote organized during the
3rd world HAI forum to rank by priority 24 actions to prevent an
impending public health catastrophe caused by the emergence and
spread of bacteria that are resistant to all antibiotics. The ranking was
organized in 4 groups corresponding to distinct categories of stakeholders.
The actions are ranked from priorities 1 to 6 (or 7) and the corresponding
ballots (voting: all forum attendees see Additional file 1: Annex 1).
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